@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RAkhus3BFJlthfNieNLrXEV8FHrUNoIZUPRcdNTUmuIIU#> .
@prefix this: <http://purl.org/np/RAkhus3BFJlthfNieNLrXEV8FHrUNoIZUPRcdNTUmuIIU> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  rdf:OBJECT rdfs:label "with a trend toward increased risk of infection" .
  
  rdf:PREDICATE rdfs:label "associated" .
  
  rdf:SUBJECT rdfs:label "Administration of Tocilizumab an receptor blocker" .
}

sub:provenance {
  sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" .
  
  sub:assertion prov:generatedAtTime "2023-06-06T14:28:55.421650"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4692-1377 .
  
  rdf:Statement rdfs:label "Administration of Tocilizumab, an interleukin-6 receptor blocker, was associated with a trend toward increased risk of infection." .
  
  rdfs:ABSTRACT-UID rdfs:label "dalsi84v" .
  
  rdfs:TRIPLE-UID rdfs:label "dalsi84v-TRIPLE-ABSTRACT-24" .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "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";
    npx:hasSignature "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";
    npx:hasSignatureTarget this: .
  
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}